A Pharmacokinetics/Dynamics Ib Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
Clinical trial NCT02522234 · COMPLETED
Trial details
- NCT number
- NCT02522234
- Sponsor
- EVIVE Biotechnology
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-25
- Primary completion
- 2015-08-19
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.